# Remedo Clinitech Pvt

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/remedo-clinitech-pvt

- Industry: Healthcare IT
- Headquarters: Delhi, India
- Website: www.remedoapp.com
- Total disclosed funding: $0.4M
- Latest round: Seed (Jul 14, 2022)
- Investors on record: 2

## About

Remedo Clinitech Pvt Ltd is a digital healthcare marketing platform that empowers medical practices to enhance patient engagement and improve online visibility through innovative marketing solutions.Founded in 2016 in Delhi, India, Remedo Clinitech Pvt Ltd specializes in providing digital marketing solutions tailored for healthcare providers. The founding team includes Harsh Bansal, Richeek Arya, and Ruchir Mehra, who have substantial experience in the healthcare technology sector. In July 2022, the company secured INR 35.07 million in Seed funding from Inflection Point Ventures and Vistra ITCL, raising its total funding to INR 35.07 million and achieving a current valuation of INR 347.983 million. The company has completed four funding deals, with its most recent deal occurring in July 2022.Remedo offers a comprehensive suite of digital marketing services aimed at enhancing the online presence of healthcare providers. Key offerings include an AI-driven insights dashboard, SEO-optimized websites, social media management, and targeted advertising campaigns. The platform is designed to cater to the unique needs of healthcare practitioners, helping them acquire and retain patients while improving their overall visibility through tools like Google business profiles and real-time analytics. Remedo's clientele primarily consists of healthcare practitioners, clinics, and medical facilities, predominantly located in North America and parts of Europe.For the most recent fiscal year 2023, Remedo reported a revenue of INR 250,451.2 and an EBITDA of -INR 184,676.1. Revenue is primarily generated through subscription models and service fees associated with its digital marketing solutions, allowing clients to engage in monthly subscriptions for the platform and additional services such as pay-per-click advertising and website design.Remedo plans to leverage its recent Seed funding of INR 35.07 million raised in July 2022 to enhance its product offerings and expand into new markets. The company aims to launch upcoming features that further integrate AI capabilities into its platform to improve client engagement and analytics. Additionally, Remedo is targeting expansion into additional regions within Europe and Asia by the end of 2024. The funding will facilitate the development of new products and enhance marketing efforts to support this growth strategy.

## Funding rounds

- Seed, Jul 14, 2022, $0.4M — Inflection Point Ventures, Vistra ITCL

## Investors

- Inflection Point Ventures (https://capitalatlas.ai/funds/inflection-point-ventures) — Seed
- Vistra ITCL — Seed